Open Access

Relationship between anthropometric measures and early electrocardiographic changes in obese rats

  • Steve Kyende Mutiso1,
  • Dennis Kipkemoi Rono1 and
  • Frederick Bukachi1Email author
Contributed equally
BMC Research Notes20147:931

https://doi.org/10.1186/1756-0500-7-931

Received: 26 November 2013

Accepted: 12 December 2014

Published: 18 December 2014

Abstract

Background

The degree of cardiovascular function impairment parallels the degree of obesity and obese subjects have abnormal changes on the electrocardiogram (ECG). Early ECG changes in obesity have not been previously studied. The objective of the present study was to determine the early ECG changes in obese rats and their relationship with anthropometric measurements.

Results

At seven weeks all rats in the experiment were obese and in sinus rhythm. In the experiment resting heart rate was increased (364 ± 13 vs. 313 ± 12 bpm, P <0.01). In contrast, the following parameters were shortened: QRS duration (77 ± 3.6 vs. 65 ± 2.6 ms, P < 0.01); QT interval (102 ± 5.2 vs. 88 ± 3.7 ms, P < 0.05); Q wave amplitude (−12.8 ± 1.0 vs. -5.1 ± 0.9 μv, P <0.01); and T wave amplitude (18.8 ± 1.4 vs. 5.8 ± 0.6, P <0.01). All other ECG parameters remained unchanged. With increased weight the resting heart rate (r =0.46, P < 0.01) and R wave amplitude (r = 0.60, P < 0.01) increased.

Conclusion

Early in obesity there are no rhythm disturbances, but resting heart rate is increased. The QRS duration is shortened and Q and T-wave amplitudes reduced signifying ventricular changes related to impaired myocardial depolarization and repolarization. Furthermore, weight gain is correlated with an increase in heart rate and accentuation of the R wave amplitude.

Keywords

Obesity Electrocardiography Anthropometrics

Background

Obesity is a growing problem worldwide especially due to dietary malpractice and physical inactivity. Obesity is considered a prime risk factor for cardiovascular disease (CVD) [1]. It is now acknowledged that obesity is a global epidemic. About 1.6 billion people are overweight, of these 400 million adults and 40 million children are obese worldwide [2]. Obesity levels have risen sharply across the globe with it being considered an independent risk factor for CVD in children, and is moreover associated with reduced life expectancy [3]. The global epidemic of obesity results from a combination of genetic susceptibility, increased availability of high-energy foods and decreased requirement for physical activity in modern society [4].

Hyper caloric diets have previously been shown to induce obesity in rats [5, 6]. Thus, providing an animal model for studying obesity - an important step towards better understanding of the pathophysiology of CVD in obese humans. The use of sucrose solution has also been described in the literature [6, 7]. However the use of a combination of the two is a novel idea.

Obesity has numerous adverse effects on cardiovascular health and these include: hypertension, heart failure, atrial fibrillation, stroke, prothrombotic states, ventricular arrhythmias and venous disease [8]. It has also been associated with the causation of diseases which are major risk factors for CVD, such as type II diabetes and sleep apnoea [8]. These effects of obesity are achieved through the metabolic consequences and pathological effects on cardiovascular function [3].

Changes in various electrocardiographic parameters have previously been observed in obese humans. A low QRS voltage, flattening of the T-wave in the inferolateral leads and left shifts of the P and QRS axes in obese patients was shown as a significant finding by Eisensten et al. [9]. In addition, increased heart rate, PR interval, QRS duration; QTc interval and voltage (R + S or Q wave in leads I, II and III) and the leftward shift in the QRS vector have all been reported with increasing obesity in another study [10]. Obesity also affects P wave dispersion and duration [11]. The change in P wave dispersion may be closely related to the clinical parameters such as BMI [12]. Furthermore, it has been shown that obesity is associated with increasing of the QT interval [13, 14]. The aim of the present study was to induce obesity using a hyper caloric diet and subsequently determine the earliest attendant ECG changes.

Methods

Study design

The study was experimental study design with two randomized independent groups within which there were repeated measures.

Study animals

Forty male Wistar rats were used for the study. The animals were randomly allocated into two equal groups (n = 20), the control and experimental group. They were housed in eight plastic wire meshed cages (30 cm × 15 cm × 12 cm) placed on a 0.75 m raised surface in the labaratory animal house. Wood shavings used as beddings were replaced every 2 days. They were kept in light controlled quarters at a 12 hour light–dark cycle (lights on: 07:00–19:00 h and lights off: 19:00–07:00 h). All experimental procedures on the rats were conducted during the light cycle. The average room temperature was kept at 21 ± 1°C. The control group was fed on the normal rat diet and water ad libitum while the experimental group was provided with the high fat (HF) diet and 30% sucrose solution ad libitum.

Induction of obesity

Two pelleted semi purified, nutritionally complete experimental diets were used . Animals in the experimental group were fed on a HF diet consisting of 30% fat, supplemented with 30% sucrose solution and the control with a normal diet consisting of 5% fat, for a period of seven weeks.

The HF diet was freshly prepared and it contained 30 g of fat/100 g of pellets (25 g of vegetable oil and 5 g of soybean oil). To formulate the feed, vegetable oil was added to a commercially available normal pellet food (Unga Feeds Kenya Ltd, Nairobi, Kenya). The vegetable oil was chosen on the basis of its high digestibility (99.7%) [15]. The 30% sucrose solution contained 30 grams of cane sugar dissolved in 100 ml of water. The normal rat diet contains 5 g of soybean oil/100 g of pellets. Because the emphasis in the experiment was on dietary fat, the amount of protein and all of the essential minerals and vitamins required for rats were equalized for the HF and normal diets.

Determination of BMI

The weight and nose-anus length (NAL) of the rats in the control and experimental groups were measured at the start of the experiment and after seven weeks. BMI was determined by dividing the weight (g) and the square of the nose-anus length (cm). Thus, obesity was defined by a BMI of greater than 0.68 g/cm2 as previously described by Novelli et al. [6]. Rats that did not meet the BMI in the experimental group after seven weeks were to be excluded from the study. However, all the rats in the experimental group attained the target BMI and were all included.

Recording ECG

The ECG record (Lead II) of each animal was taken before and after the seven weeks. The rats were anaesthetized by use of Ketamine (0.2 mg/g bodyweight intraperitionally, IP) before recording the ECG. The ECGs were recorded by use of Power Lab Data acquisition apparatus (Model ML865, ADinstruments, Dunedin, New Zealand). The following standard ECG variables were analyzed: rhythm, heart rate, P wave amplitude and duration, PR interval, QRS duration, QT interval, QTc interval, RR interval, Q, R, S and T wave amplitudes. The QTc interval was derived from the QT interval using the Bazzet’s formula: QTc = QT Interval /√ (RR interval) [16].

Statistical analysis

Data were analyzed using the two tailed student t - test for repeated measures. Pearson correlation analysis was used for estimating the relationship between anthropometric measures and ECG parameters. The data for each group were expressed as mean ± SEM. P value < 0.05 was considered statistically significant.

Ethical considerations

The study protocol was approved by the University of Nairobi Ethics review Committee. The study was conducted in accordance with the internationally accepted principles for laboratory animal use and care [17]. Animals were handled with care and in accordance with the FELASA guidelines [18].

Results

General anthropometric characteristics of study animals

The general characteristics of the rats at the beginning and at the end of the study are shown in Table 1. At the beginning of the experiment there were no significant anthropometric differences between the control and experimental groups. However, after seven weeks, there were significant changes in weight (229.2 ± 7.26 vs. 314.7 ± 5.78 g, P < 0.01), nose-anus length (20.18 ± 0.18 vs. 21.14 ± 0.16 cm, P <0.01) and BMI (0.56 ± 0.01 vs. 0.70 ± 0.01 g/cm2, P <0.01) between the control and experimental groups.
Table 1

General characteristics at baseline and at seven weeks

 

Control

Experimental

P value

 

(n = 20)

(n = 20)

 

Weight (g)

   

 Baseline

214.7 ± 9.96

216.4 ± 8.59

NS

 At seven weeks

229.2 ± 7.26

314.7 ± 5.78

<0.01

Nose-anus length (cm)

   

 Baseline

19.59 ± 0.30

19.17 ± 0.26

NS

 At seven weeks

20.18 ± 0.18

21.14 ± 0.16

<0.01

BMI (g/cm 2 )

   

 Baseline

0.55 ± 0.02

0.58 ± 0.01

NS

 At seven weeks

0.56 ± 0.01

0.70 ± 0.01

<0.01

Values expressed as mean ± S.E.M. NS, not significant.

The progressive changes in BMI in both groups over the seven week period are shown in Figure 1. None of the animals in the control group were obese at week 7. In contrast, the percentages of the rats in the experimental group that attained the greater than 0.68 g/cm2 increased sharply after week 2 (Figure 2).
Figure 1

Weight changes between the two groups over the seven week period. Error bars represent the S.E.M. *control vs. experimental (P < 0.01).

Figure 2

Percentage rats acquiring a BMI of >0.68 g/cm 2 over the seven week period.

ECG measurements

Rat and human ECGs are similar except for the absence of an ST segment in the former (Figure 3). At baseline ECG parameters were similar in both groups (Table 2). At seven weeks, however, there were significant differences (Table 2): The mean heart rate was significantly higher in the experimental group (313 ± 12 vs. 364 ± 13 beats per minute, P <0.01). Accordingly, the RR interval was also significantly shorter (198 ± 8.3 vs. 170 ± 6.2 ms, P <0.01). There were no changes in the P wave amplitude and duration, as well as the PR interval. The QRS duration and the QT interval were significantly shorter in the experimental group compared to the controls (77 ± 3.6 vs. 65 ± 2.6 ms, P < 0.01) and (102 ± 5.2 vs. 88 ± 3.7 ms, P < 0.05) respectively. However, the QTc interval was similar in both groups. The Q wave amplitude was significantly shorter in the experimental group (−12.8 ± 1.0 vs. -5.1 ± 0.9 μv, P <0.01). There were no significant changes observed in the R and S wave amplitudes at seven weeks. However, the T wave amplitude was significantly reduced in the experimental group compared to controls (18.8 ± 1.4 vs. 5.8 ± 0.6 μv, P <0.01).
Figure 3

Normal human and rat ECGs showing the waves and time intervals. The rat ECG compared to the human ECG has both positive and negative deflections. These deflections, just like in humans, are as a result of action potentials in the myocardial cells. The positive deflections include the P, R and T waves. The negative deflections include the Q and S waves. The difference from the human ECG is the lack of an ST segment.

Table 2

ECG parameters at baseline and at seven weeks

 

Baseline.

Seven weeks.

Control

Experimental

P value

Control

Experimental

P value

Number Of rats (n)

20

20

 

20

20

 

Heart rate

342 ± 12

357 ± 13

NS

313 ± 13

364 ± 13

<0.01

RR interval (ms)

180 ± 7

172 ± 2

NS

198 ± 8.1

170 ± 6.0

<0.01

P wave amplitude (μv)

19.8 ± 1.9

22.6 ± 2.5

NS

13.9 ± 1.5

14.6 ± 1.7

NS

P wave duration (ms)

28 ± 2.0

24 ± 2.4

NS

25 ± 1.9

23 ± 1.5

NS

PR interval (ms)

30 ± 2.0

29 ± 1.3

NS

26 ± 1.9

26 ± 1.9

NS

QRS duration (ms)

81 ± 4.1

80 ± 3.3

NS

77 ± 3.6

65 ± 2.6

<0.01

QT interval (ms)

105 ± 3.6

101 ± 2.0

NS

102 ± 5.2

88 ± 3.7

<0.05

Q wave amplitude (μv)

−11.2 ± 1.4

−11.6 ± 1.5

NS

−12.8 ± 1.0

−5.1 ± 0.9

<0.01

R wave amplitude (μv)

71.7 ± 9.0

78.3 ± 10.2

NS

61.3 ± 8.4

72.3 ± 8.9

NS

S wave amplitude (μv)

−20.8 ± 2.1

−29.1 ± 5.5

NS

−28.4 ± 4.5

−26.6 ± 4.0

NS

T wave amplitude (μv)

15.9 ± 1.4

17.9 ± 1.8

NS

18.8 ± 1.4

5.8 ± 0.6

<0.01

With bivariate analysis, at the end of seven weeks positive correlations were observed in the obese group between weight and heart rate (r = 0.46, P < 0.01) and weight and R wave amplitude (r = 0.60, P < 0.01).On the other hand, a negative correlation observed was between weight and RR interval (r = −0.45, P < 0.05). These correlations were not observed in the control group (Figures 4 and 5).
Figure 4

Scatter plots showing correlations between weight and heart rate between the control and experimental groups at the end of seven weeks. NS, Not significant.

Figure 5

Scatter plots showing correlations between weight and R wave amplitude at the end of seven weeks. NS, Not significant.

Discussion

Obesity is a growing global pandemic, associated with poor diet and lack of physical exercise. In the long term, it is a major risk factor for CVD. Thus, evaluation of the cardiovascular system is essential in all obese persons. Specific ECG changes have previously been reported in obese humans without clinical symptoms [10]. But there is paucity of data in the literature regarding the progression of ECG changes with increasing weight, particularly the earliest alterations in obesity. We used an animal model to elucidate these changes.

The present study induced obesity in rats by using a hypercaloric diet - a high fat diet augmented with sucrose solution. Hypercaloric diets have previously been shown to induce obesity in rats [5, 6]. It should, however, be noted that this dietary combination is novel and led to rapid weight gain in the experimental animals. Consequently, a number of changes in anthropometric measurements were observed in these animals, namely an increase in weight, nose anus length and the BMI. Similar changes have been recently described [6, 7]. Thus, BMI in rats is a simple and easily reproducible anthropometric measure of obesity.

Following induction of obesity, changes in various ECG parameters were observed. These included, increased heart rate, shortened QRS duration, and reduced Q and T wave amplitudes. Some of these changes have previously been described in humans with established obesity especially increased heart rate ([10, 19]) and flattening of the T wave in the inferolateral leads ([9, 20]). However, the shortening of the QRS duration and Q wave amplitude observed in our study have previously not been reported. The QRS duration, which represents the period of myocardial depolarization, is consistently prolonged in established obesity in humans [10]. The decrease observed in the present study may be attributed to increased conduction rate of the impulse in the myocardium that is an accompaniment of higher resting heart rates seen in obesity. This may also be a result of a reduced ventricular refractory period and a higher velocity of ventricular contraction. The Q wave amplitude was decreased in the obese group. Although Q waves have previously been described in healthy rat ECGs [21], no study has reported them in lead II. The present study, therefore, becomes the first to describe Q waves in lead II of the ECG in healthy rats. The Q wave represents movement of the activation impulse through the septum and its decrease implies that the orientation of the septum is changing to a leftward position. This anatomical shift in septal orientation is expected in obese rats in whom the heart lies more horizontally in the chest due to increased abdominal adiposity. Similar anthropometric changes have been observed in humans [21].

Obesity in humans leads to changes in various anthropometric measurements. These include: increased BMI, waist to hip ratio and waist circumference [22]. Similar changes have recently been reported in obese rats [6] but no previous study has made an attempt to correlate these anthropometric measurements with ECG parameters. Thus, the present study becomes the first to examine this relationship. Increased weight had a positive correlation with resting heart rate. This finding, although expected, is attributable to increased body weight which is associated with increased adiposity [20]. The latter leads to a positive energy balance leading to hyperinsulinaemia and the production of excessive leptin by the adipose tissue. Consequently, this leads to hyperleptinaemia. Both hyperinsulinaemia and hyperleptinaemia lead to the activation of the sympathetic nervous system which results in increased resting heart rate [20]. This appears to be one of the earliest changes in obesity. A positive correlation between weight and the R wave amplitude was only observed in the obese group. The R wave amplitude represents ventricular activity and an increase in the amplitude may denote an increase in ventricular myocardial size. The present study did not examine changes in myocardial mass with increasing obesity. Established obesity however, has been associated with ventricular chamber dilatation due to increased cardiac workload [3]. The dilatation leads to increased wall stress, which predisposes to an increase in myocardial mass and ultimately to eccentric LV hypertrophy [3]. The positive correlation denotes that as the weight of an obese individual increases, the ventricular myocardial size increases to compensate for increased cardiac workload.

Our study was not without limitations. First, the ideal method to record ECGs in rats is without sedation as previously described by Mitchell and colleagues [23]. Ketamine has been shown to increase resting heart rate but its use in both groups provides to cancel out this effect. Moreover, anaesthetic agents have continued to be used successfully in small animal ECG studies. Secondly, the technical limitation associated with lack of equipment to record 12 lead ECG in rats limits the scope of the data obtained including determination of changes in the mean electrical axes. Thirdly, the study did not record ECGs throughout the study period but just at the start and the end. This was attributed to the study protocol where only two readings were to be taken to compare obese and non-obese groups. However, the authors intend to study the progression of ECGs from normal weight to obese subjects in a future study.

Conclusion

Early in obesity there are no rhythm disturbances, but resting heart rate is increased. The QRS duration is shortened and Q and T-wave amplitudes reduced signifying ventricular changes related to impaired myocardial depolarization and repolarization as well as changes in cardiac morphology. Furthermore, weight gain is correlated with an increase in heart rate and accentuation of the R wave amplitude.

Author’s contributions

MSK participated in the conception and design of the experiments; Collection, analysis and interpretation of data and drafting the whole article and revising it critically for important intellectual content. RDK participated in the experiments; collection and analysis of data; and revising the article. BF was the supervisor of the research project and participated in the conception and design of the experiments; collection and interpretation of data; and the final drafting of the article. All authors read and approved the final manuscript.

Notes

Abbreviations

BMI: 

Body mass index

CVD: 

Cardiovascular disease

ECG: 

Electrocardiogram

FELASA: 

Federation of European Laboratories Animal Science Associations

HF: 

High fat

NAL: 

Nose-anus length

SEM: 

Standard error of the mean.

Declarations

Acknowledgements

To the academic and technical staff of the department of Medical Physiology, University of Nairobi for the support, equipment and facilities provided to conduct this project.

Authors’ Affiliations

(1)
Department of Medical Physiology, University of Nairobi

References

  1. Yusuf S, Hawken S, Ounpuu S, et al: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9.PubMedView ArticleGoogle Scholar
  2. World Health Organization: WHO/NUT/NCD/98.1. Obesity: preventing and managing the global epidemic: report of a WHO Consultation on Obesity, Geneva document. 1998Google Scholar
  3. Poirier P, Thomas DG, Bray GA, Yuling H, Stern JF: Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss. JAMA. 2006, 26: 968-978.Google Scholar
  4. Kopelman PG: Obesity as a medical problem. Nature. 2000, 404: 635-643.PubMedGoogle Scholar
  5. Von Diemen V, Trindade EN, Trindade MR: Experimental model to induce obesity in rats. Acta Cir Bras. 2006, 21: 425-429.PubMedView ArticleGoogle Scholar
  6. Novelli ELB, Diniz YS, Galhardi CM, Ebaid GMX, Rodrigues HG, Mani F, Fernandes AAH, Cicogna CH, Novelli JVLB: Anthropometrical parameters and markers of obesity in rats. Lab Anim. 2007, 41: 111-119. 10.1258/002367707779399518.PubMedView ArticleGoogle Scholar
  7. Peckham SL, Entenman C, Carrol HW: The influence of a hypercaloric diet on gross body and adipose tissue composition in the rat. J Nutr. 1962, 77: 187-198.PubMedGoogle Scholar
  8. Lavie CJ, Milani RV: Obesity and cardiovascular disease: the Hippocrates paradox?. J Am Coll Cardiol. 2003, 42: 677-679. 10.1016/S0735-1097(03)00784-8.PubMedView ArticleGoogle Scholar
  9. Eisenstein I, Edelstein J, Sarma R, Sanmarco M, Selvester RH: The electrocardiogram in obesity. J Electrocardiol. 1982, 5: 115-118.View ArticleGoogle Scholar
  10. Frank S, Colliver JA, Frank A: The electrocardiogram in obesity: statistical analysis of 1,029 patients. J Am Coll Cardiol. 1986, 7: 295-299. 10.1016/S0735-1097(86)80494-6.PubMedView ArticleGoogle Scholar
  11. Russo V, Ammendola E, De Crescenzo I, Docimo L, Santangelo L, Calabrò R: Severe obesity and P-wave dispersion: the effect of surgically induced weight loss. Obes Surg. 2008, 1: 90-96.View ArticleGoogle Scholar
  12. Kosar F, Aksoy Y, Fahri A, Keskin L, Sahin I: P-Wave Duration and Dispersion in Obese Subjects. Ann Noninvasave Electrocardiol. 2008, 13: 3-7. 10.1111/j.1542-474X.2007.00194.x.View ArticleGoogle Scholar
  13. Russo V, Ammendola E, De Crescenzo I, Ricciardi D, Capuano P, Topatino A, Docimo L, Santangelo L, Calabrò R: Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. Obes Surg. 2007, 7: 857-865.View ArticleGoogle Scholar
  14. Papaioannou A, Michaloudis D, Fraidakis O, Petrou A, Chaniotaki F, Kanoupakis E, Stamatiou G, Melissas J, Askitopoulou H: Effects of weight loss on Qt interval in morbidly obese patients. Obes Surg. 2003, 13: 869-873. 10.1381/096089203322618687.PubMedView ArticleGoogle Scholar
  15. Nutrient requirements for laboratory animals, fourth revised edition. 1995, [http://www.nap.edu/catalog/4758/nutrient-requirements-oflaboratory-animals-fourth-revised-edition-1995 [Accessed on 30th December 2014]
  16. Bazett HC: An analysis of time relations of the electrocardiograms. Heart. 1920, 7: 353-370.Google Scholar
  17. National Institutes of health: NIH publication No. 86–23. Guide for care and use of laboratory animals. 1985Google Scholar
  18. Voipio M, Baneux P, de Segura G, Hau J, Wolfensohn S: Guidelines for the veterinary care of laboratory animals: report of the FELASA/ECLAM/ESLAV Joint Working Group on Veterinary Care. Laboratory Animals. 2008, 42: 1-11.PubMedView ArticleGoogle Scholar
  19. Rhamouni K, Correira MLG, Haynes WG, Marl AL: Obesity-Associated Hypertension: New Insights into Mechanisms. Hypertension. 2005, 45: 9-14. 10.1161/01.HYP.0000151325.83008.b4.View ArticleGoogle Scholar
  20. Fraley MA, Birchem JA, Senkottaiyan N, Alpert MA: Obesity and the electrocardiogram. Obes Rev. 2005, 6: 275-281. 10.1111/j.1467-789X.2005.00199.x.PubMedView ArticleGoogle Scholar
  21. Wexler BC, Willen D, Greenberg BP: Electrocardiographic differences between non-arteriosclerotic and arteriosclerotic rats. Atherosclerosis. 1973, 18: 129-140. 10.1016/0021-9150(73)90124-X.PubMedView ArticleGoogle Scholar
  22. Corral AR, Somers VK, Johnson SJ, Thomas RJ, Clavell ML, Korinek J, Allison TG, Batsis JA, Kuniyoshi FH, Jimenez FL: Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008, 32: 959-966. 10.1038/ijo.2008.11.View ArticleGoogle Scholar
  23. Mitchell G, Jeron A, Koren G: Measurement of heart rate and QT interval in the conscious mouse. Am J Physio Heart Circ Physiol. 1998, 274: 747-751.Google Scholar

Copyright

© Mutiso et al.; licensee BioMed Central. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.